Advertisement
Canada markets close in 2 hours
  • S&P/TSX

    21,813.46
    +105.02 (+0.48%)
     
  • S&P 500

    4,985.40
    -25.72 (-0.51%)
     
  • DOW

    38,018.64
    +243.26 (+0.64%)
     
  • CAD/USD

    0.7276
    +0.0013 (+0.18%)
     
  • CRUDE OIL

    83.41
    +0.68 (+0.82%)
     
  • Bitcoin CAD

    88,924.24
    +2,638.40 (+3.06%)
     
  • CMC Crypto 200

    1,386.69
    +74.07 (+5.64%)
     
  • GOLD FUTURES

    2,409.40
    +11.40 (+0.48%)
     
  • RUSSELL 2000

    1,944.22
    +1.26 (+0.06%)
     
  • 10-Yr Bond

    4.6250
    -0.0220 (-0.47%)
     
  • NASDAQ

    15,375.66
    -225.84 (-1.45%)
     
  • VOLATILITY

    18.60
    +0.60 (+3.33%)
     
  • FTSE

    7,895.85
    +18.80 (+0.24%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • CAD/EUR

    0.6827
    +0.0006 (+0.09%)
     

Better Growth Stock: AbbVie vs. Pfizer

Better Growth Stock: AbbVie vs. Pfizer

AbbVie (NYSE: ABBV) and Pfizer (NYSE: PFE) are two of the world's biggest pharmaceutical companies, and the similarities don't end there. The case for AbbVie as a growth stock can't avoid two issues: the decline of Humira, and the stagnation of its oncology portfolio.